Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer

Colony-stimulating factor-1 receptor (CSF-1R) signaling promotes an immune suppressive microenvironment enriched in M2 macrophages. Given that CSF-1R inhibitors are under investigation in clinical trials, including in breast cancer, CSF-1R expression and association with immune biomarkers could iden...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nazia Riaz, Samantha Burugu, Angela S. Cheng, Samuel C. Y. Leung, Dongxia Gao, Torsten O. Nielsen
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/abeea43bae854238ba522f7fc6b26fb2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:abeea43bae854238ba522f7fc6b26fb2
record_format dspace
spelling oai:doaj.org-article:abeea43bae854238ba522f7fc6b26fb22021-11-25T17:03:47ZPrognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer10.3390/cancers132257692072-6694https://doaj.org/article/abeea43bae854238ba522f7fc6b26fb22021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5769https://doaj.org/toc/2072-6694Colony-stimulating factor-1 receptor (CSF-1R) signaling promotes an immune suppressive microenvironment enriched in M2 macrophages. Given that CSF-1R inhibitors are under investigation in clinical trials, including in breast cancer, CSF-1R expression and association with immune biomarkers could identify patients who derive greater benefit from combination with immunotherapies. TIMER2.0 and bc-GenExMiner v4.7 were used to assess the correlation of <i>CSF1R</i> mRNA with immune infiltrates and prognosis. Following a prespecified training–validation approach, an optimized immunohistochemistry assay was applied to assess CSF-1R on carcinoma cells and macrophages on breast cancer tissue microarray series representing 2384 patients, coupled to comprehensive clinicopathological, biomarker, and outcome data. Significant positive correlations were observed between <i>CSF1R</i> mRNA and immune infiltrates. High carcinoma CSF-1R correlated with grade 3 tumors >2 cm, hormone receptor negativity, high Ki67, immune checkpoint biomarkers, and macrophages expressing CSF-1R and CD163. High carcinoma CSF-1R was significantly associated with poor survival in univariate and multivariate analyses. Adverse prognostic associations were retained in ER+ cases regardless of the presence of CD8+ T cells. CSF-1R+ macrophages were not prognostic. High carcinoma CSF-1R is associated with aggressive breast cancer biology and poor prognosis, particularly in ER+ cases, and identifies patients in whom biomarker-directed CSF-1R therapies may yield superior therapeutic responses.Nazia RiazSamantha BuruguAngela S. ChengSamuel C. Y. LeungDongxia GaoTorsten O. NielsenMDPI AGarticlecolony-stimulating factor-1 receptorimmunohistochemistryprognosisestrogen receptor-positive breast cancerinvasive breast cancerimmune check pointsNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5769, p 5769 (2021)
institution DOAJ
collection DOAJ
language EN
topic colony-stimulating factor-1 receptor
immunohistochemistry
prognosis
estrogen receptor-positive breast cancer
invasive breast cancer
immune check points
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle colony-stimulating factor-1 receptor
immunohistochemistry
prognosis
estrogen receptor-positive breast cancer
invasive breast cancer
immune check points
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Nazia Riaz
Samantha Burugu
Angela S. Cheng
Samuel C. Y. Leung
Dongxia Gao
Torsten O. Nielsen
Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer
description Colony-stimulating factor-1 receptor (CSF-1R) signaling promotes an immune suppressive microenvironment enriched in M2 macrophages. Given that CSF-1R inhibitors are under investigation in clinical trials, including in breast cancer, CSF-1R expression and association with immune biomarkers could identify patients who derive greater benefit from combination with immunotherapies. TIMER2.0 and bc-GenExMiner v4.7 were used to assess the correlation of <i>CSF1R</i> mRNA with immune infiltrates and prognosis. Following a prespecified training–validation approach, an optimized immunohistochemistry assay was applied to assess CSF-1R on carcinoma cells and macrophages on breast cancer tissue microarray series representing 2384 patients, coupled to comprehensive clinicopathological, biomarker, and outcome data. Significant positive correlations were observed between <i>CSF1R</i> mRNA and immune infiltrates. High carcinoma CSF-1R correlated with grade 3 tumors >2 cm, hormone receptor negativity, high Ki67, immune checkpoint biomarkers, and macrophages expressing CSF-1R and CD163. High carcinoma CSF-1R was significantly associated with poor survival in univariate and multivariate analyses. Adverse prognostic associations were retained in ER+ cases regardless of the presence of CD8+ T cells. CSF-1R+ macrophages were not prognostic. High carcinoma CSF-1R is associated with aggressive breast cancer biology and poor prognosis, particularly in ER+ cases, and identifies patients in whom biomarker-directed CSF-1R therapies may yield superior therapeutic responses.
format article
author Nazia Riaz
Samantha Burugu
Angela S. Cheng
Samuel C. Y. Leung
Dongxia Gao
Torsten O. Nielsen
author_facet Nazia Riaz
Samantha Burugu
Angela S. Cheng
Samuel C. Y. Leung
Dongxia Gao
Torsten O. Nielsen
author_sort Nazia Riaz
title Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer
title_short Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer
title_full Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer
title_fullStr Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer
title_full_unstemmed Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer
title_sort prognostic significance of csf-1r expression in early invasive breast cancer
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/abeea43bae854238ba522f7fc6b26fb2
work_keys_str_mv AT naziariaz prognosticsignificanceofcsf1rexpressioninearlyinvasivebreastcancer
AT samanthaburugu prognosticsignificanceofcsf1rexpressioninearlyinvasivebreastcancer
AT angelascheng prognosticsignificanceofcsf1rexpressioninearlyinvasivebreastcancer
AT samuelcyleung prognosticsignificanceofcsf1rexpressioninearlyinvasivebreastcancer
AT dongxiagao prognosticsignificanceofcsf1rexpressioninearlyinvasivebreastcancer
AT torstenonielsen prognosticsignificanceofcsf1rexpressioninearlyinvasivebreastcancer
_version_ 1718412795407499264